TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiation therapy

被引:0
|
作者
Gao, Chan [1 ]
机构
[1] City Hope Natl Canc Inst, Duarte, CA USA
关键词
D O I
10.1158/1535-7163.TARG-13-C285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C285
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
    Jin, Yizhen
    Zhuang, Yuxin
    Dong, Xiaowu
    Liu, Mei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 841 - 851
  • [22] Grancalcin (GCA) modulates Toll-like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9
    Kim, Tae Whan
    Hong, Seunghee
    Talukder, Amjad H.
    Pascual, Virginia
    Liu, Yong-Jun
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (03) : 712 - 724
  • [23] TLR9 signaling defines distinct prognostic subsets in CLL
    Efremov, Dimitar G.
    Bomben, Riccardo
    Gobessi, Stefania
    Gattei, Valter
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 371 - 386
  • [24] Correlation among Tonsillar TLR9 Expression, TLR9 SNP and Clinical Outcomes of Tonsillectomy with Steroid Pulse Therapy
    Sato, Daisuke
    Suzuki, Yusuke
    Kano, Tatsuya
    Suzuki, Hitoshi
    Yokoi, Hidenori
    Horikoshi, Satoshi
    Ikeda, Katsuhisa
    Tomino, Yasuhiko
    RECENT ADVANCES IN TONSILS AND MUCOSAL BARRIERS OF THE UPPER AIRWAYS, 2011, 72 : 190 - 190
  • [25] TLR9 stability and signaling are regulated by phosphorylation and cell stress
    Hasan, Maroof
    Gruber, Erika
    Cameron, Jody
    Leifer, Cynthia A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (03) : 525 - 533
  • [26] IRAP+ endosomes restrict TLR9 activation and signaling
    Babdor, Joel
    Descamps, Delphyne
    Adiko, Aime Cezaire
    Tohme, Mira
    Maschalidi, Sophia
    Evnouchidou, Irini
    Vasconcellos, Luiz Ricardo
    De Luca, Mariacristina
    Mauvais, Francois-Xavier
    Garfa-Traore, Meriem
    Brinkmann, Melanie M.
    Chignard, Michel
    Manoury, Benedicte
    Saveanu, Loredana
    NATURE IMMUNOLOGY, 2017, 18 (05) : 509 - 518
  • [27] Role of immunostimulatory DNA and TLR9 in gene therapy
    Yasuda, Kei
    Wagner, Hermann
    Takakura, Yoshinobu
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2006, 23 (02): : 89 - 109
  • [28] Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells
    Kitahata, Yuji
    Kanuma, Tomohiro
    Hayashi, Masayuki
    Kobayashi, Nobuyoshi
    Ozasa, Koji
    Kusakabe, Takato
    Temizoz, Burcu
    Kuroda, Etsushi
    Yamaue, Hiroki
    Coban, Cevayir
    Yamamoto, Takuya
    Kobiyama, Kouji
    Aoshi, Taiki
    Ishii, Ken J.
    ONCOTARGET, 2016, 7 (31) : 48860 - 48869
  • [29] IRAP+ endosomes restrict TLR9 activation and signaling
    Joel Babdor
    Delphyne Descamps
    Aimé Cézaire Adiko
    Mira Tohmé
    Sophia Maschalidi
    Irini Evnouchidou
    Luiz Ricardo Vasconcellos
    Mariacristina De Luca
    Francois-Xavier Mauvais
    Meriem Garfa-Traore
    Melanie M Brinkmann
    Michel Chignard
    Bénédicte Manoury
    Loredana Saveanu
    Nature Immunology, 2017, 18 : 509 - 518
  • [30] Development of inhibitory peptide to control TLR9 signaling pathway
    Singh, Sujay
    Lee, Hyun-Ku
    Singh, Gita
    Luo, Yi Feng
    Chitta, Sriram
    Rosenberg, Jonathan
    JOURNAL OF IMMUNOLOGY, 2012, 188